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Integrins, selectins and
CAMs - the 'glue of life'
Steven Froese, Enid Shephard, Susan Adams,
Simon Robson, Ralph Kirsch
The ability of cells to adhere to one another and to
surrounding structural tissue proteins is essential to the life
process of all multicellular organisms. Specific receptors,
their Iigands and their counter-receptors, collectively
referred to in Time' as the 'glue of life', play a major role in
maintaining organ and tissue integrity. Progress in molecular
and cell biology has advanced knowledge of these cellular
adhesion molecules (CAMs) to a point where they will soon
be part of the everyday vocabulary of practising doctors.
CAMs, first recognised for their role in the organisation of
developing embryological neural tissue, respond to neural,
endocrine and paracrine stimuli and in turn influence
immune and inflammatory cell function, cell repair processes
and the integrity of specialised organs and tissues. The
development of therapeutic agents which influence cell
adhesion processes offers a new and exciting approach to
old diseases such as tuberculosis and cancer.
CAMs in diseases rare to
common
As is so often the case in medicine, the importance of
CAMs was first appreciated when scientists found a small .
group of patients in whom they were deficient. The
condition, leucocyte adhesion deficiency (LAD), is
characterised by recurrent bacterial infections, poor wound
healing, lack of pus formation, chronic peripheral blood
granulocytosis and abnormal leucocyte function. These
unfortunate patients were shown to have a rare inherited
deficiency of the P2-integrins found on leucocyte
membranes! Depending on the severity and extent of the
CAM deficiency, death can occur in the first 2 years unless
cwrative bone marrow transplantation is performed.
The discovery that a deficiency of CAMs was associated
with increased susceptibility to infection led scientists to
examine their role in a variety of common conditions.
Subjects included normal neonates and premature infants
who were shown to have neutrophils with a blunted ability to
adhere to, and migrate through, vascular endothelium in
order to reach sites of infection and inflammation.3 More
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recently we have found similarly impaired neutrophil-
endothelial cell interactions in patients with chronic liver
disease.' Other workers have shown low levels of essential
CAMs on p-cells in patients with Burkitt's lymphoma.'
Because adhesion between leucocytes is central to the
regulation of Iymphocyte proliferation, abnormal
adhesiveness caused by dysfunctional CAMs is thought to
result in poor immune surveillance and an increased risk of
cancer, Certain inflammatory processes are associated with
acquired leucocyte adhesion defects and impaired
neutrophil adhesion to endothelium. Patients with sepsis,
adult respiratory distress syndrome and myocardial
infarction are among those affected,6
The nature and function of
CAMs
The search for the processes which mediate cell-cell
recognition and interaction was based on the assumption
that, in order to establish and maintain specialised tissues
and organs, multicellular organisms must have a mechanism
by which cells interact with each other and with constituents
of the extracellular matrix within which they exist. The initial
evidence to support this hypothesis was the identification of
a specific neuronal cell surface protein which mediated early
embryonic events such as the orderly layering of neural
tissue.' Apart from their role in ontogeny, cellular interactions
are critical for the differentiation and function of the immune
system. Leucocytes achieve continual immune surveillance
of the body by circulating in the'bloodstream and, when
called upon, bind to the vascular endothelium and migrate
into tissues where they either become local effector cells or
perform other functions before returning to the circulation
via the lymphatic system. The interaction of leucocytes with
endothelial cells is the primary and essential step in
leucocyte migration into any tissue. This process is
particularly well illustrated by neutrophil recruitment into
sites of inflammation and by Iymphocyte development,
recirculation and migration to predestined sites within the
body.
The classification of CAMs
Pro-adhesive protein receptors are found on leucocytes and
both resting and stimulated endothelium. These receptors
have now been classified and characterised into three main
superfamilies, the immunoglobulin superfamily, the integrins
and the selectins.8-12
The immunoglobulin superfamily
Members of the immunoglobUlin superfamily are
characterised by one or more immunoglobulin-like
domain(s), a transmembrane region and a cytoplasmic tail
(when the receptor member is membrane-bound). Examples
of these proteins include intercellular adhesion molecules
(ICAM-1 and 2) and vascular cell adhesion molecules
(VCAM-1) which are found on endothelium and are critical
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The integrins
The second superfamily, the integrins, are heterodimeric
transmembrane glycoproteins which consist of two non-
covalently associated a- and ~-subunits. The receptor family
is made up of varying combinations of one of 14 distinct
a-subunits (a,-a,J and one of 8 ~-subunits (~,-~J. The
ligand-binding site of integrins is formed by sequences from
both subunits but is named after the contributing
~-chain which confers its specificity. The integrin structure is
stabilised by its cytoplasmic domain which connects it to
the cytoskeleton." Integrins are found on a large variety of
cells. Individual cells express more than one type of integrin
and these in turn often differ in their state of activation.
Integrins may bind to cell surface adhesion proteins or to
counter-receptors on other cells, allowing for cell-cell
interactions and/or adhesion between cells of the same type
(homotypic) or of different types (heterotypic). These
counter-receptors may be members of the immunoglobulin
superfamily (ICAM-1, ICAM-2, VCAM-1). Several integrins
bind to extracellular matrix proteins, both soluble in the form
of glycoprotein or peptide sequences, and fixed solid-phase
moieties; this allows for cell-extracellular matrix interactions.
Examples of such extracellular matrix ligands include
fibronectin, fibrin, vitronectin and laminin. The recognition
site for many of the integrins that bind to the extracellular
matrix is often a short peptide sequence held in a specific
conformational state. The first to be defined was the
tripeptide Arg-Gly-Asp (RGO) which is found in the adhesion
domains of fibronectin, fibrinogen and a number of other
adhesive proteins." Further sequences have since been
recognised, and these include Lys-Glu-Ala-Gly-Asp-Val
(KQAGOV) and others with no RGO sequences.
The selectins
The selectins are another superfamily of structurally rela.ted
molecules that mediate adhesive interactions of
endothelium, leucocytes and platelets. These reactions are
necessary for vascular homeostasis and inflammation but if
disregulated, contribute to inflammatory tissue injury and
pathological thrombosis. Selectins recognise sialylated
glycans attached to target cells. P-selectin is an int~gral
membrane protein present in subcellular granules of
platelets and endothelial cells :and rapidly translocated to the
membrane following specific stimulation. E-selecti'!: an
endothelial cell selectin, is synthesised and expressed only
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Fig. 1. Schematic representation of neutrophil adherence and migration through vascular endothelium. Under normal conditions, the blood
flow presents neutrophils to the endothelium but no interaction occurs (a). At sites of inflammation (b), the vascular endothelial surfaces
express the counter-receptor to selectins normally present on neutrophil surfaces, and the resultant interaction allows the neutrophil to
'roll' along the vessel. This process slows the white cell enough to allow stronger adhesion or 'tethering' to occur between the cell types
(c). The tethering action is mediated by selective upregulation of integrins on the neutrophil, a process requiring further signalling which, if
not present, reverses the adhesion and allows the neutrophil to rejoin the circulation. If signalling occurs, neutrophil surface selectins are
immediately shed, further integrins are recruited towards the adhesion process and tight adhesion follows. Following tight adhesion,
transmigration between endothelial cells occurs through co-ordinated interactions between various groups of adhesion molecules. The
migration along a chemotactic gradient allows the neutrophil to enter inflammatory sites and phagocytose bacterial organisms and cellular
debris (d). Pictures are not drawn to scale.
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PHASE 2 Conversion to memory Iymphocytes
Fig. 2(a): Schematic representation of Iymphocyte trafficking. In the first phase, immature Iymphocytes are initially released from the bone
marrow from where they travel to the thymus to undergo primary differentiation into T-cell subsets. They are released from the thymus into
the circulation as naive Iymphocytes bearing high numbers of selectins on their surface. This configuration allows them to be preferentially
taken up into lymphoid tissue, as seen in phase 2, where they encounter antigen through adhesive contact with resident antigen-
processing cells. Further activation and differentiation occur and the Iymphocyte is re-released into the circulation via the thoracic duct as
a 'memory' Iymphocyte expressing fewer selectins and a higher number of integrins on its surface. This Iymphocyte, depicted in phase 3, is
now able to perform immune surveillance by being primed to a particular antigen which, if re-encountered by the Iymphocyte, will initiate








Fig. 2(b). A schematic representation showing the adhesion receptors predominantly involved in co-ordinating Iymphocyte interactions with
endothelial cells during the various phases of trafficking shown in Fig. 2(a).
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mediates Iymphocyte and granulocyte endothelial cell
interactions. L-selectin is constitutively expressed on
granulocytes, Iymphocytes and monocytes and is shed from
their membranes after cellular activation. An endothelial
glycoprotein acts as a ligand for L-selectin.'4-17 The complex,
selective recognition and binding processes which involve
each of the three CAM superfamilies are described in detail
in a recent review.'·
CAMs and immune surveillance
An integrated immune response capable of maintaining
constant body surveillance is dependent to a large degree
on adhesive proteins. This concept is well illustrated by
leucocyte recruitment into inflamed tissue and by
Iymphocyte trafficking. In both cases leucocyte-endothelial
cell recognition is essential for adhesion which, in turn, is an
obligatory prerequisite for migration of cells to their target.
Leucocyte recruitment (Fig. 1)
Leucocyte-endothelial cell recognition is an active process
requiring three sequential events for attachment of
leucocytes to occur. These steps, which include a phase of
reversible adhesion, leucocyte activation and activation-
dependent binding, are most commonly seen in neutrophil
endothelial interactions in venules soon after tissue injury.
Reversible adhesion, which slows the flow of circulating
neutrophils and causes them to 'roll' along the margins of
blood vessels, depends on activated endothelium
expressing functional selectins which bind loosely to
carbohydrate moieties on neutrophils and the simultaneous
expression on the neutrophils of functional selectins which
bind to endothelial counter-receptors. This process is
transient unless followed by further leucocyte and
endothelial activation. Tissue damage results in macrophage
and Iymphocyte synthesis of an array of cytokines, including
IL-1, IL-4, IL-6 and tumour necrosis factor (TNF). Exposure
to these cytokines converts the endothelial surface from an
anticoagulant to a procoagulant surface. This results in the
generation of thrombin, fibrin deposition and adhesion of
granulocytes to the endothelium. TNF and interleukins 1 and
8 stimulate neutrophils to express 132-integrins which are
normally stored in intracellular adhesomes, a form of
neutrophil granule; together with endothelial-derived
platelet-activating factor these ensure that the integrins are
in a functionally activated state.
The activation of 13,-integrins by these chemotactic factors
constitutes the third step in the binding process. Activation
changes the configuration of the receptor and results in
stable and sustained attachment of neutrophils to counter-
receptors expressed by the activated endothelial cells. Thus
attachment, the first step of leucocyte migration, is a tightly
controlled process which can be modulated at any of the
three stages described above.'·
Leucocytes circulating in intact blood vessels express
inactive forms of CAMs on their surface as do normal
endothelial cells, but both must, upon stimulation, be able,
through signalling events, to upregulate selectively the
activation state of those same CAMs in order to allow for
adhesion and targeting. Signalling may occur via cytokines
as well as by the presence of ligand in the receptor site of
the surface CAM. Both lead to changes in intracellular
tyrosine kinase/phosphorylase pathways which initiate
further activation of the cell surface proteins. In the case of
already activated cells, inactivation may be mediated by
both pathways. In this way leucocytes are able to interact
with a host of targets by varying the status of individual
groups of surface adhesion receptors in response to
appropriate signals.'9
Lymphocyte trafficking (Fig. 2)
Lymphocytes are unique in their ability to patrol the body by
continuously migrating from the blood into tissue, organs
and lymphoid systems, utilising surface CAMs to facilitate
recognition and response to antigen. There may be two
distinct phases in the life cycle of Iymphocytes. In the first
phase Iymphocytes are considered to be naive while in the
second they are endowed with 'memory'. Naive cells are
immature Iymphocytes which have not yet encoun.tered
antigen. These cells leave the thymus and enter lymphoid
tissue where they come into contact with antigen tflrough
. adhesive interactions with antigen-processing cells. In order
to enter lymphoid tissues these naive cells must express a
high number of L-selectins on their surface (as opposed to
memory cells). These facilitate adherence to lymphatic
postvenular vascular endothelium and migration into
lymphatic tissue. On contact with foreign antigen, the naive
Iymphocyte is stimulated to express different adhesion
molecules on its surface and is transformed into a memory
cell which enters the circulation via the thoracic duct.
Memory cells express various integrins, including 13, and 132
integrins, which facilitate enhanced binding to their
respective ligands, ICAM-1, VCAM-1 and extracellular matrix
proteins. The site at which the conversion from naive to
memory cells occurs is important in that each tissue, e.g.
skin, gut, has particular antigens which are present in local
lymphatic tissue. After re-entering the circulation, memory
cells preferentially return to the tissue where the initial
stimulating response originated, a phenomenon thought to
be brought about by specific and differential surface·
expression of CAMson the Iymphocyte and local
endothelium. This process is termed homing. With the
increased levels of CAMs on their surface, memory cells can
also migrate into inflamed non-lymphoid tissue for
surveillance. When stimulated by contact with foreign .
antigen to which it is 'primed,' a memory Iymphocyte
becomes an effector cell and is able to bring about local and
systemic host responses.
Platelet adhesion
Platelets, unlike Iymphocytes and neutrophils, do not adhere
to normal vasculature. However, any disruption of the
endothelial surface caused by damage, inflammation,
complement or atherosclerotic plaque, exposes collagen
and other extracellular matrix proteins which interact with
specific platelet receptors and mediate platelet adhesion.
The extent of vascular injury determines whether platelets
ensure normal haemostasis or cause abnormal thrombotic
events. Platelet plugs at sites of vascular injury limit blood
loss but, when associated with atherosclerotic vessels,
impair blood flow. Thus adhesion of platelets to the
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subendothelium may initiate either haemostasis or
thrombosis. The interaction of platelets with damaged
endothelium is via platelet-associated uH -, ~,- and ~3­
integrins and specific extracellular matrix proteins, laminin,
collagen, fibronectin and vitronectin. This process activates
platelets and is characterised by a conformational change in
several platelet-associated receptors (e.g. the fibrinogen
receptor Gpllb/llla, ~3 family), translocation of P-selectin to
the membrane and thrombin generation. Platelet plugs are
formed through sequential steps of adhesion, activation
and aggregation. Thrombin generated as described above,
or released from platelets, initiates fibrin formation.
Neutrophil and monocyte accumulation in thrombi are
mediated via cellular adhesion through neutrophil and
monocyte ~2-integrin interaction with fibrin and with cell
surface carbohydrate binding to platelet-expressed
P-selectin. Thus CAMs mediate a variety of reactions which
not only allow cells to reach their target but to exert effects
upon arrival in the tissues.
Bacterium host cell interactions
occur via integrins
It is now well known that adhesion molecules play a major
role in host-pathogen interactions. Viral, bacterial and
protazoan pathogens utilise a wide range of host cell
surface receptors, including the integrin receptors, to gain
entry into cells. Poliovirus and rhinovirus infect cells via the
ICAM-1 molecule; Bordetella pertussis, Legionella
pneumophilia and Leishmania donovani all bind to the
CD11 b/CD18 receptor, while Salmonella typhimurium
appears to gain entry through the epidermal growth factor
receptor.20 Enteropathogenic Yersinia pseudotuberculosis
interacts with mammalian cells through the interaction of the
outer membrane proteins, invasin and adhesin YadA, with
several members of the ~,-integrin family.21 By attachment to
~,-integrins, these species 'appear to exploit existing signal
transduction pathways intimately, to attach themselves to
and enter the host cell. Several species of Gram-negative
and Gram-positive bacteria, including Mycobacterium
tuberculosis, contain cell surface proteins capable of binding
to the extracellular matrix protein, fibronectin.22 This possibly
intensifies their virulence by promoting adherence to
mucosal surfaces. Since fibronectin binding to ~, -integrins is
important for transduction of cell signals, fibronectin-binding
bacterial constituents may alter the functions of many cell
types and their interaction with the extracellular matrix.
Therapeutic modulation of CAMs
The recognition that cell adhesion plays an important role in
various disease states has raised the exciting prospect of
therapeutic intervention via modulation of CAMs. Various
methods of therapy are currently available or are being
tested. In some conditions the focus is directed at
increasing the ability to express CAMs. This currently
includes bone marrow transplantation in LAD. In other
conditions, notably sepsis, where excessive expression of
certain CAMs leads to leucocyte aggregation and
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intravascular sludging, therapy aims at reducing functional
CAMs. This includes the use of monoclonal antibodies
directed against CAMs, and the administration of soluble
adhesion receptor proteins (known natural in vivo inhibitors)
and peptides which bind to CAMs or to their counter-
receptors. Anti-adherence therapy has proved useful in
some forms of infection, such as meningitis and malaria, as
well as in sepsis-associated acute respiratory distress
syndrome where leucocyte accumulation in the lung
contributes to organ injury.23 Antibodies against integrins,
selectins and immunoglobulin adhesion receptors have been
therapeutically beneficial in animal models of asthma and
arthritis. ".25
The localisation and accumulation of neutrophils in
reperfused ischaemic tissue following myocardial infarction
appears to be of critical importance in determining the
incidence of complications as well as the degree of damage.
Studies in animal models have shown that antibodies
against CAMs markedly decrease ischaemic injury and the
resultant complications. Antibodies specific to platelet CAMs
also inhibit thrombosis in vivo and have potential use in
myocardial infarction, unstable angina and cerebrovascular
disease.2•.2'
T-Iymphocyte accumulation mediates the damage caused
by rejection of transplanted organs. Antibodies directed
against these T-Iymphocytes and their specific receptors,
e.g. OKT3, are routinely used in this situation.
Cell adhesion is an important process in leucocyte
function. An increased understanding of the structure and
function of CAMs, as well as their modulation by various
cytokines, is rapidly leading to a new approach to the
management of everyday diseases.
We thank Professors C. Trey and S. Louw for their advice
and constructive criticism.
Dr Steven Froese was a recipient of the SAGES/Glaxo
Fellowship Award. We thank SAGES and Glaxo for this
generous support.
REFERENCES
1. Thompson D. The 91ue of life. Time 1992; 38: 58-59.
2. Anderson DC, Springer T. Leukocyte adhesion deficiency: an inherited defect in
the Mac-l. LFA-l. and p150,95 glycoproteins. Ann Rev Med 1987; 38: 175.
3. Anderson DC, Rothlein R. Martin SO, Krater SS, Wayne Smith C. Impaired
transendothelial migration by neonatal neutrophils: abnormalities of mac-l
(CDll b/CD18}-dependent adherence reactions. Blood 1990; 76: 2613-2621.
4. Froese S, Robson SC, Kirsch RE. Neutrophil adhesion abnormalities in chronic
liver disease (manuscript in preparation).
5. Makgoba MW, Bernard A, Saunders ME. Cell adhesion/signalling: biology and
clinical applications. Eur J Clin Invest 1992; 22: 443-453.
6. Fein AM, Grant MM, Niederman MS, Kantrowitz N. Neutrophil-endothelial cell
interaction in critical illness. Chest 1991; 99: 1456-1462.
7. Edelman GM. Cell adhesion molecules. Science 1983; 219: 450-462.
8. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-
434.
9. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and
integrins. Science 1987; 238: 491-497.
10. Hynes RO. lntegrins: a family of cell surface receptors. Celf 1987; 48: 549-554.
11. Patarroyo M, Makgoba MW. Leukocyte adhesion to cells in immune and
inflammatory responses. Lancet 1989; 2: 1139-1141.
12. Hartan JM. Leukocyte-endothelial cell interactions. Blood 1985; 65: 513-525.
13. Ruoslahti E. Integrins. J Clin Invest 1991; 87: 1-5.
14. Bevilacqua MP, Stengeln S, Gumbrone MA, Seed B. ELAM-l: an inducible
receptor for neutrophils related to complement regulatory proteins and lectins.
Science 1989; 243: 1160-1165.
15. Geng J. Bevilacqua MP, Moore KL, et al. Rapid neutrophil adhesion to activated
endothelium mediated by GMP-140. Nature 1990; 343: 757-760.
16. Stoolman LM. Adhesion molecules controlling Iymphocyte migration. Ce" 1989;
56: 907.
17. Kishimoto TK, Wanock RA, Jutila MA, et al. Antibodies against human neutrophil
LECAM-1 and ELAM-l inhibit a common CD la-independent adhesion pathway
in vitro. Blood 1991; 78: 805-811-
18. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to
specificity and diversity. Ce111991; 67: 1033-1036.




SAMJ Volume 84 No. 11 November 1994
1
763
20. Brett SJ, Mazuvov AV, Charles IG, TIte JP. The invasin protein of Yersinia spp.
provides co-stimulatory activity to human T cells through interaction with 6\
integrins. Euro J Immuno/1993; 23: 1608-1614.
21. Bliska JB. Copass MC, Falksow S. The Yersinia pseudotuberculosis adhesin YadA
mediates intimate bacterial attachment to and entry into Hep-2 cells. Infect
Immun 1993; 61: 3914-3921.
22. Abou-Zeld C, Garba T, Lathigra R. et al. Genetic and immunological analysis of
Mycobacterium tuberculosis fibronectin binding proteins. Infect Immun 1991; 59:
2712-2718.
23. Saez-Harens X, Jafari HS, Severier C. et al. Enhanced attenuation of meningeal
inflammation and brain edema by concomitant administration of anti-C018
monoclonal antibodies and dexamethasone in experimental haemophilus
meningitis. J CUn Invest 1991; 88: 2003-2011.
24. Wegner CO. Grundel RH, Reilly p. Haynes N, Letts G, Rothlein A. Intercellular
adhesion molecute-l (ICAM-1) in the pathogenesis of asthma. Science 1990; 247:
456-459.
25. Vedder NB. Winn RK. Rice CL, Chi EY, Arforf KE, Hanan JM. A monoclonal
antibody to the adherence-promoting leukocyte glycoprotein COlS, reduces
organ injury and improves survival from haemorrhagic shock and resuscitation in
rabbits. J Clin Invest 1988; 81: 939-944.
26. Falanga PS, Butcher EC. Late treatment with anti-LFA-1 (COlla) antibody
prevents cerebral malaria in a mouse model. Eur J Immunol 1991; 21: 2259-2263.
27. Ma X, Tsao PS, Lefer AM. Antibody to COlS exerts endothelial and cardiac
protective effects in myocardial ischaemia and reperfusion. J CUn Invest 1991;
88: 1237-1243.
Accepted 2 May 1994.
_ Volume 84 No. 11 November 1994 SAMJ
Dokter en digter
Vreemde Iiefde
(in offerande aan: Anairda)
Jou Iiefde is 'n helder vlam
Wat stil en suiwer voor my brand
En elke nag sy wierook hef.
Ek hoop eendag
Oor my sal die Suiderkruis
se kalm sterre skyn.
Hoe kan jy weet, in jou vroee jare
Dat hierdie wonder aan jou sou geskied
Draaikolk van sterre en rooi duiseling
o Iiefde, Iiefde wat my alles gee
Uit watter dieptes het jy my gehaal!
Ek min jou, soos die vlakpatryse die veld
Saam salons twee nie meer die vuur
Van sterre sien nie, maar daar bly
'n Gloedvolle herinnering vir jou en my
o liefde dieper as die diepste see
en ruimer as die sterbestrooide nag
Straal tot waar die verste sterre bewe
Ek wonder of jy soms
Of jy nog aan die nagte dink
o welbeminde?
Ek het my aan jou oorgegee
So onvoorwaardelik dat ek soms vrees
Vernietiging is al wat uiteindelik vir my kan wees
Hier voor my oor die bree helling hang
Die trae skemerfng van verdonkerde lande
Hoe kan my ryk alleen wees jou vervang?
In die verhongering
van 'n Iiefdelose nag
Kan 'k veiling ween
Die sterre dans en vrolik skyn
Stil my hart se bittere pyn
Middernagtelike ure kan die skim 'n tydjie keer.
Vergeefs strek ek die hande om te pluk!
want onbereikbaar aan die takke hang
Die ryp rooi vrugte van jou sielsgeluk
AI wat ek het, is joune as jy terug wil keer
AI wat bly is die bleek wit rose van verdriet
Maar net die wysheid van die hart
Kan wit ontrafel van die swart
Hoe mooi is alles nou vir my!
Uit die swart leegtes van die Niet
wat ruis deur die soet goue lied
Uit die groot harp van GOD
'Ekuphumleni'
